NCT00204490 2024-05-16
Soy Isoflavones and Breast Cancer Risk Reduction
The University of Texas Medical Branch, Galveston
Phase 2 Completed
Clinical Trials
8 trialsNCT00354432 2021-09-28
Soy Protein/Effexor Hormone Therapy for Prostate Cancer
Wake Forest University Health Sciences
Phase 3 Terminated
NCT00499408 2018-11-21
Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer
Wake Forest University Health Sciences
Phase 2 Completed
NCT00245518 2017-10-13
Effect of Soy on Cognition and Hot Flashes in Men With Prostate Cancer Undergoing Testosterone Suppression Therapy
Johns Hopkins University
Phase 4 Completed
NCT00031720 2016-07-13
Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00276835 2015-04-10
Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer
Northwestern University
Phase EARLY_PHASE1 Completed
NCT00036686 2012-09-24
Isoflavones in Treating Women Who Have Breast Cancer and Are Planning to Undergo Mastectomy or Lumpectomy
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Terminated
NCT00596895 2011-09-20
Isoflavone in Prostate-specific Antigen Recurrent Prostate Cancer
University of Florida
Phase 2 Completed